Senate Vote Monday Could End Hemp Delay — What the Budd Amendment Means for CBD and Hemp Products

Editor's Note (Aug 8, 2026):

The Senate voted overnight and passed the Continuing Resolution with the hemp delay provision (Section 2019) intact. The Budd amendment to strip the delay was defeated. The House must now vote to reconcile. Read our full coverage of the Senate vote result →

---

The U.S. Senate is scheduled to vote Monday, August 10, on a Continuing Resolution (CR) that includes a provision delaying the federal hemp THC ban until December 11, 2026. But there is a serious catch. Sen. Ted Budd (R-NC) has filed an amendment that would strip that delay from the bill entirely. Thanks to a ruling by the Senate Parliamentarian, his amendment needs only a simple majority to pass. If it does, the ban on hemp products containing more than 0.4mg of total THC per container kicks in on November 12 as originally scheduled, with no runway for businesses or consumers. If it fails, the industry gets one more month to prepare while lawmakers work toward a longer-term fix.

What Is the Federal Hemp THC Ban?

To understand Monday's vote, you need to know what is already law.

In November 2025, President Trump signed an agriculture spending bill that included a sweeping redefinition of hemp. Under Section 781 of that law, hemp products are now limited to 0.4 milligrams of total THC per finished container — not per serving, per container. That is a standard so low it would effectively ban approximately 95% of the hemp-derived THC products currently on the market. Think delta-8 gummies, THCA flower, hemp-derived delta-9 beverages, and many full-spectrum CBD products. Most of these contain anywhere from 2.5mg to 10mg of THC per unit, well above the 0.4mg threshold.

The original effective date for this new definition was set at November 12, 2026. Any product exceeding the 0.4mg cap would be reclassified as a controlled substance under federal law — illegal to sell, ship, or possess in states where marijuana remains prohibited.

Current legal status: Hemp products containing more than 0.4mg of total THC per container remain federally legal to sell and purchase through November 11, 2026 — unless Monday's vote changes that timeline. No federal charges are being brought under the new standard today.

For a full breakdown of how the Senate CR and the hemp delay provision came together, see our earlier coverage: Federal Hemp THC Ban: Senate Votes to Delay November Deadline.

What Is Happening Monday, August 10?

The Senate is voting on a Continuing Resolution — a stopgap spending bill that keeps the federal government funded through December 11, 2026. CRs are routine. This one is not.

Senate appropriators included a provision — sometimes called Section 2019 — inside the CR that would push the hemp THC ban's effective date from November 12 to December 11, 2026. A one-month delay, matching the length of the CR itself. The Senate voted 89 to 4 on August 3 to advance the overall CR to the floor, a lopsided tally that made the bill look like a done deal.

Then Sen. Ted Budd filed his amendment.

What Is the Budd Amendment?

Sen. Ted Budd (R-NC) wants to remove the hemp delay from the CR entirely. His argument is simple and blunt: hemp-derived THC products are unregulated, dangerous intoxicants being marketed to children through gas stations and convenience stores, and every extra day the delay buys is another day those products stay on shelves.

Budd calls them "gas-station marijuana candy."

The key development came on August 6, 2026, when the Senate Parliamentarian ruled Budd's amendment germane to the CR. That ruling changed everything. A non-germane amendment would have needed 60 votes to overcome a procedural hurdle. A germane amendment needs only 50 votes — a simple majority. With a 53-seat Republican caucus, Budd does not need a single Democrat to vote for his amendment. He needs to hold roughly half his own party.

Backing Budd are Senators Tom Cotton (R-AR) and Pete Ricketts (R-NE), along with a bloc of social conservatives who have been pushing to close what they call the hemp loophole since the 2018 Farm Bill opened it.

What Happens If the Budd Amendment Passes?

If the Senate adopts the Budd amendment and the final CR is accepted by the House, the hemp delay provision is gone. The November 12 effective date holds. Hemp products exceeding 0.4mg of total THC per container become federally illegal on that date.

The practical consequences are significant:

• Retailers selling delta-8, THCA, hemp-derived delta-9, and most full-spectrum CBD products would need to clear inventory by November 11 or risk federal exposure.

• Consumers in DC, Maryland, Virginia, and every other state would lose access to legally purchased hemp-derived THC products overnight at the federal level.

• Manufacturers and distributors serving the $28 billion hemp industry would face immediate shutdown of their product lines with roughly 90 days of notice.

• Payment processors like Square had already announced plans to cut off hemp merchants by October 2026 in anticipation of the ban — that deadline moves up alongside enforcement.

There is an additional wrinkle. Even the Senate's delay provision was not a complete reprieve. Reports indicate the Senate CR would still allow the ban on synthetic cannabinoids — those not naturally produced by the cannabis plant — to proceed on the original November 12 date. Only naturally derived hemp products would get the one-month extension under the delay language.

What Happens If the Budd Amendment Fails?

If the amendment fails and the CR passes with the delay intact, hemp businesses and consumers get until December 11, 2026 before the 0.4mg standard takes effect. That is one additional month.

The delay is not a reprieve — it is a clock reset. Senators Rand Paul (R-KY) and Amy Klobuchar (D-MN), who led the bipartisan push for the delay, have argued the extra time is needed to advance a more durable legislative fix. The Cannabinoid Safety and Regulation Act — a framework that would create age-verification requirements, potency standards, and label mandates for hemp products rather than an outright ban — is the alternative path some lawmakers are pursuing. The December CR cycle would be the next opportunity to either pass that legislation or extend the delay again.

But there is one more obstacle even if the Budd amendment fails in the Senate. The House CR does not contain a hemp delay provision at all. The House is in recess until August 31. If the two chambers cannot reconcile their versions of the bill, the entire CR could stall — raising the prospect of a government shutdown that would have its own cascading effects on federal agencies and enforcement timelines.

The White House Factor

One of the stranger storylines in this fight is the White House's position. President Trump personally called Sen. Budd on August 4 and 5 to lobby him against the amendment. Trump's argument, according to reports, was that the White House was developing a broader regulatory framework for medicinal THC products and that an immediate ban would complicate that effort.

White House officials, including CMS administrator Dr. Mehmet Oz, separately lobbied senators against the Budd amendment, with Oz reportedly arguing the ban would hurt seniors' access to full-spectrum CBD products.

The pressure from 1600 Pennsylvania Avenue did not move Budd. He filed his amendment anyway.

The White House's intervention drew scrutiny of its own. Reports emerged that Bret Worley — the son-in-law of White House Chief of Staff Susie Wiles — is CEO of MC Nutraceuticals, a major hemp supplier that would benefit financially from the delay. The White House denied that Wiles played any role in the administration's lobbying position, but the optics added a conflict-of-interest dimension to an already messy legislative fight.

What DMV Consumers and Hemp Buyers Need to Know

If you buy delta-8, THCA flower, hemp-derived delta-9 products, or full-spectrum CBD in DC, Maryland, or Virginia, here is what Monday's vote means for you.

• Right now, nothing has changed. The products available at licensed retailers and through Bud Lords same-day delivery are federally legal to purchase today. The 0.4mg cap is not yet in effect.

• The November 12 date is the hard deadline to watch. Whether the Senate passes the Budd amendment or not, hemp-derived THC products face a legal cliff in the near term. The question Monday's vote answers is whether that cliff is November 12 or December 11.

• DC, Maryland, and Virginia each have their own cannabis frameworks. Adult-use marijuana is legal in all three jurisdictions. Hemp products sold through state-licensed cannabis retailers operate under state law as well as federal law. A federal hemp ban does not automatically close down licensed adult-use dispensaries. But hemp-specific products sold outside the licensed cannabis framework — at smoke shops, convenience stores, and online retailers — would lose their federal legal cover if the ban takes effect.

• No decision has been made yet. Monday's vote is the decision point. Watch for results on August 10.

Browse currently available hemp and cannabis products at the Bud Lords shop.

What to Watch Next

• Monday, August 10: Senate floor vote on the CR and the Budd amendment. If the amendment is adopted, the hemp delay is gone. If defeated, the CR passes with the December 11 delay, pending House reconciliation.

• August 31: House returns from recess. Conference negotiations between House and Senate versions of the CR begin.

• November 12: The hard ban date if no delay passes.

• December 11: The extended deadline if the Senate delay survives.

• Cannabinoid Safety and Regulation Act: The industry's preferred long-term fix. Watch for markup hearings in the September through November window.